Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac Receives $9.6 Million Grant to Build E71 Vaccine Facility

publication date: Apr 24, 2014
Sinovac Biotech will receive a $9.6 million government grant to build a production facility for its Enterovirus 71 vaccine against hand foot and mouth disease (HFMD). The company said the grant was a response to epidemic levels of HFMD in China and the government's desire to develop China biotech. Sinovac must use the money to complete construction of its GMP-compliant production facility, which will have an annual capacity of 20 million doses of EV71 vaccine, and to commercialize the vaccine in China. More details....

Stock Symbol: (NSDQ: SVA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital